Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

Details for Australian Patent Application No. 2007216320 (hide)

International Classifications

Event Publications

4 September 2008 PCT application entered the National Phase

PCT publication WO2007/093824 Priority application(s): WO2007/093824

1 October 2009 Assignment before Grant

Summit (Cambridge) Limited The application has been assigned to Orient Pharma (Samoa) Co., Ltd.

28 October 2010 Application Accepted

Published as AU-B-2007216320

24 February 2011 Amendment Made

The nature of the amendment is: Amend to the co-inventor name from Roach, Alan George to Roach, Alan Geoffrey

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.